Gang Cheng Selected Research

olamufloxacin

10/2006

Distribution characteristics of orally administered olamufloxacin, a newly synthesized fluoroquinolone antibacterial, in lung epithelial lining fluid and alveolar macrophage in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gang Cheng Research Topics

Disease

78	Neoplasms (Cancer) 02/2022 - 03/2004
15	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2022 - 02/2008
11	Inflammation (Inflammations) 01/2022 - 07/2002
10	Neoplasm Metastasis (Metastasis) 01/2022 - 03/2004
9	Breast Neoplasms (Breast Cancer) 01/2021 - 03/2011
8	Hemorrhage 01/2022 - 07/2004
6	Adenocarcinoma of Lung 01/2021 - 08/2006
6	Glioblastoma (Glioblastoma Multiforme) 01/2020 - 02/2011
6	Body Weight (Weight, Body) 06/2019 - 09/2004
6	Asthma (Bronchial Asthma) 01/2019 - 08/2002
6	Reperfusion Injury 08/2007 - 08/2003
5	Wounds and Injuries (Trauma) 05/2022 - 07/2010
5	Pain (Aches) 01/2022 - 03/2014
5	Nasopharyngeal Carcinoma 10/2021 - 12/2002
5	Pancreatic Neoplasms (Pancreatic Cancer) 05/2021 - 08/2015
5	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021 - 06/2010
5	Lung Neoplasms (Lung Cancer) 01/2021 - 08/2006
5	Infections 01/2014 - 12/2002
4	Glioma (Gliomas) 01/2022 - 01/2018
4	Carcinoma (Carcinomatosis) 09/2020 - 01/2012
4	Leukemia 01/2020 - 01/2011
4	Type 2 Diabetes Mellitus (MODY) 06/2019 - 01/2016
4	Thrombosis (Thrombus) 04/2019 - 09/2011
4	Cardiovascular Diseases (Cardiovascular Disease) 12/2017 - 12/2005
4	Hepatocellular Carcinoma (Hepatoma) 10/2014 - 12/2002
4	Atherosclerotic Plaque (Atheroma) 09/2013 - 10/2006
4	Obesity 03/2007 - 07/2004
4	Hypersensitivity (Allergy) 10/2003 - 05/2003
3	Cardiotoxicity 01/2022 - 01/2013
3	Fibrosis (Cirrhosis) 01/2022 - 03/2006
3	Hypoxia (Hypoxemia) 01/2022 - 10/2008
3	Bacterial Infections (Bacterial Infection) 01/2022 - 12/2003
3	Diarrhea 02/2021 - 01/2018
3	Stomach Neoplasms (Stomach Cancer) 10/2020 - 11/2016
3	Carcinogenesis 01/2020 - 01/2018
3	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 01/2011
3	Lymphoma (Lymphomas) 01/2020 - 10/2008
3	Stroke (Strokes) 10/2018 - 01/2011
3	Hemolysis 02/2018 - 04/2011
3	Ischemic Stroke 08/2017 - 01/2011
3	Skeletal Abnormalities Mandibular Hypoplasia Auditory Canal Atresia Short Stature 01/2017 - 10/2007
3	Hyperplasia 05/2008 - 01/2007
2	Parkinsonian Disorders (Parkinsonism) 04/2022 - 07/2017
2	Ascites 01/2022 - 01/2016

Drug/Important Bio-Agent (IBA)

23	Pharmaceutical PreparationsIBA 05/2022 - 05/2005
15	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2002
8	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 03/2004
7	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2013
7	Biomarkers (Surrogate Marker)IBA 01/2022 - 06/2004
7	Therapeutic UsesIBA 01/2021 - 07/2006
7	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 01/2011
6	Metformin (Glucophage)FDA LinkGeneric 01/2022 - 01/2016
6	Adenosine Triphosphate (ATP)IBA 01/2020 - 08/2003
5	HydrogelsIBA 05/2022 - 05/2006
5	ErbB Receptors (EGF Receptor)IBA 02/2022 - 06/2015
5	triphenylphosphoniumIBA 01/2022 - 10/2011
5	EnzymesIBA 01/2022 - 03/2004
5	Biological ProductsIBA 10/2020 - 10/2012
5	Superoxides (Superoxide)IBA 01/2020 - 08/2015
5	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2020 - 08/2015
5	Paclitaxel (Taxol)FDA LinkGeneric 06/2019 - 03/2009
5	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2018 - 08/2011
5	AntioxidantsIBA 01/2018 - 06/2008
5	Messenger RNA (mRNA)IBA 01/2015 - 01/2005
5	CytokinesIBA 01/2013 - 07/2002
4	Phosphotransferases (Kinase)IBA 01/2022 - 12/2017
4	Cisplatin (Platino)FDA LinkGeneric 02/2021 - 09/2002
4	Tyrosine Kinase InhibitorsIBA 01/2020 - 06/2015
4	Ethylene Glycol (Monoethylene Glycol)IBA 12/2019 - 10/2007
4	Hypoglycemic Agents (Hypoglycemics)IBA 12/2017 - 02/2012
3	Gefitinib (Iressa)FDA Link 02/2022 - 08/2010
3	InterleukinsIBA 01/2022 - 08/2002
3	Small Interfering RNA (siRNA)IBA 01/2022 - 02/2014
3	Oxidants (Oxidizing Agents)IBA 01/2020 - 01/2018
3	Ointments (Pastes)IBA 06/2019 - 08/2010
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2019 - 11/2011
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2018 - 10/2006
3	Vitamin E FDA LinkGeneric 10/2018 - 06/2008
3	Temozolomide (Temodar)FDA LinkGeneric 10/2018 - 12/2015
3	nitroxylIBA 01/2018 - 10/2011
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 08/2017 - 10/2011
3	Hydroxyl RadicalIBA 01/2017 - 12/2008
3	Anaplastic Lymphoma KinaseIBA 12/2016 - 08/2015
3	Bevacizumab (Avastin)FDA Link 07/2015 - 04/2010
3	ChitosanIBA 10/2014 - 03/2009
3	AntigensIBA 11/2011 - 03/2004
3	Interleukin-12 (IL 12)IBA 02/2007 - 12/2002
3	Insulin-Like Growth Factor I (IGF-1)IBA 02/2007 - 10/2006
2	Ether (Diethyl Ether)IBA 01/2022 - 01/2019
2	CationsIBA 01/2022 - 01/2013
2	Electron Transport Complex III (Coenzyme Q-Cytochrome-c Reductase)IBA 01/2022 - 10/2020
2	Blood Glucose (Blood Sugar)IBA 01/2022 - 09/2017

Therapy/Procedure

33	Therapeutics 02/2021 - 06/2003
21	Drug Therapy (Chemotherapy) 07/2021 - 09/2002
6	Radiotherapy 07/2021 - 03/2004
4	Immunotherapy 07/2021 - 06/2003
3	Liver Transplantation 01/2022 - 09/2004
3	Lasers (Laser) 01/2021 - 09/2011
3	Photochemotherapy (Photodynamic Therapy) 01/2021 - 06/2008
3	Aftercare (After-Treatment) 08/2020 - 03/2006